Skip to Main Content

Advertisement

American Association for Cancer Research Logo Open Menu
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 20, Issue 9
1 September 2021
Molecular Cancer Therapeutics Cover Image for Volume 20, Issue 9
All Issues
  • Cover Image

    Cover Image

    Issue cover image
    SENTI-101 is a novel allogeneic cell therapy for the treatment of peritoneal carcinomatosis, including advanced ovarian cancer. Genetically modified mesenchymal stem cells deliver IL-12 and IL-21 to peritoneal tumors, attracting and activating immune cells. Read the full article on page 1508.
  • PDF Icon PDF LinkTable of Contents
  • PDF Icon PDF LinkEditorial Board
ISSN 1535-7163
EISSN 1538-8514

Highlights

Selected Articles from This Issue
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

MCT First Disclosures

TPX-0131, a Potent CNS-penetrant, Next-generation Inhibitor of Wild-type ALK and ALK-resistant Mutations
Brion W. Murray; Dayong Zhai; Wei Deng; Xin Zhang; Jane Ung; Vivian Nguyen; Han Zhang; Maria Barrera; Ana Parra; Jessica Cowell; Dong J. Lee; Herve Aloysius; Evan Rogers
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Featured Image
SENTI-101, a Preparation of Mesenchymal Stromal Cells Engineered to Express IL12 and IL21, Induces Localized and Durable Antitumor Immunity in Preclinical Models of Peritoneal Solid Tumors
Alba Gonzalez-Junca; Frances D. Liu; Archana S. Nagaraja; Alyssa Mullenix; Chen-Ting Lee; Russell M. Gordley; Daniel O. Frimannsson; Ori Maller; Brian S. Garrison; Dharini Iyer; Anissa Benabbas; Tiffany A. Truong; Allison Quach; Mengxi Tian; Rowena Martinez; Rishi Savur; Alyssa Perry-McNamara; Denny Nguyen; Niran Almudhfar; Carmina Blanco; Christina Huynh; Asish Nand; Yu-An E. Lay; Ashita Magal; Sravani Mangalampalli; Philip J. Lee; Timothy K. Lu; Gary Lee
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Open the PDF for in another window

Reviews

Current Development of Glioblastoma Therapeutic Agents
Zilai Wang; Norton P. Peet; Pin Zhang; Yuwei Jiang; Lijun Rong
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
T-Cell Receptor Mimic Antibodies for Cancer Immunotherapy
Zhijian Duan; Mitchell Ho
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Strategies in Overcoming Homologous Recombination Proficiency and PARP Inhibitor Resistance
Nidhi Goel; McKenzie E. Foxall; Carly Bess Scalise; Jaclyn A. Wall; Rebecca C. Arend
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Small Molecule Therapeutics

Suppression of Extracellular Vesicle VEGF-C–mediated Lymphangiogenesis and Pancreatic Cancer Early Dissemination By a Selective HDAC1/2 Inhibitor
Chu-An Wang; Chien-Feng Li; Rho-Chi Huang; Yo-Hua Li; Jing-Ping Liou; Shaw-Jenq Tsai
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Open the PDF for in another window
VLX600 Disrupts Homologous Recombination and Synergizes with PARP Inhibitors and Cisplatin by Inhibiting Histone Lysine Demethylases
Thomas L. Ekstrom; Nicholas M. Pathoulas; Amelia M. Huehls; Arun Kanakkanthara; Larry M. Karnitz
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Open the PDF for in another window
ONC212 is a Novel Mitocan Acting Synergistically with Glycolysis Inhibition in Pancreatic Cancer
Isacco Ferrarini; Anna Louie; Lanlan Zhou; Wafik S. El-Deiry
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Open the PDF for in another window
Phase 0 Clinical Trial of Everolimus in Patients with Vestibular Schwannoma or Meningioma
Matthias A. Karajannis; Audrey Mauguen; Ekrem Maloku; Qingwen Xu; Erin M. Dunbar; Scott R. Plotkin; Anna Yaffee; Shiyang Wang; J. Thomas Roland; Chandranath Sen; Dimitris G. Placantonakis; John G. Golfinos; Jeffrey C. Allen; Nicholas A. Vitanza; Luis A. Chiriboga; Robert J. Schneider; Jingjing Deng; Thomas A. Neubert; Judith D. Goldberg; David Zagzag; Filippo G. Giancotti; Jaishri O. Blakeley
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Targeting TfR1 with the ch128.1/IgG1 Antibody Inhibits EBV-driven Lymphomagenesis in Immunosuppressed Mice Bearing EBV+ Human Primary B-cells
Laura E. Martínez; Tracy R. Daniels-Wells; Yu Guo; Larry I. Magpantay; Pierre V. Candelaria; Manuel L. Penichet; Otoniel Martínez-Maza; Marta Epeldegui
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Open the PDF for in another window
β-Catenin Attenuation Inhibits Tumor Growth and Promotes Differentiation in a BRAFV600E-Driven Thyroid Cancer Animal Model
Minjing Zou; Huda A. BinEssa; Yousif H. Al-Malki; Suhad Al-Yahya; Monther Al-Alwan; Ibrahim Al-Jammaz; Khalid S.A. Khabar; Falah Almohanna; Abdullah M. Assiri; Brian F. Meyer; Ali S. Alzahrani; Futwan A. Al-Mohanna; Yufei Shi
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Open the PDF for in another window
Radiopotentiation Profiling of Multiple Inhibitors of the DNA Damage Response for Early Clinical Development
Sonja J. Gill; Paul W.G. Wijnhoven; Jacqueline H.L. Fok; Rebecca L. Lloyd; Jonathan Cairns; Joshua Armenia; Jenni Nikkilä; Alan Lau; Christopher J. Bakkenist; Susan M. Galbraith; Conchita Vens; Mark J. O'Connor
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal Cancer
Nyree Crawford; Katie J. Stott; Tamas Sessler; Christopher McCann; William McDaid; Andrea Lees; Cheryl Latimer; Jennifer P. Fox; Joanne M. Munck; Tomoko Smyth; Alpesh Shah; Vanessa Martins; Mark Lawler; Philip D. Dunne; Emma M. Kerr; Simon S. McDade; Vicky M. Coyle; Daniel B. Longley
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
C/EBPβ/AEP Signaling Regulates the Oxidative Stress in Malignant Cancers, Stimulating the Metastasis
Kecheng Lei; Seong Su Kang; Eun Hee Ahn; Chun Chen; Jianming Liao; Xia Liu; Hua Li; Laura E. Edgington-Mitchell; Lingjing Jin; Keqiang Ye
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Open the PDF for in another window
SHP2 Inhibition Enhances the Effects of Tyrosine Kinase Inhibitors in Preclinical Models of Treatment-naïve ALK-, ROS1-, or EGFR-altered Non–small Cell Lung Cancer
Hirohisa Kano; Eiki Ichihara; Hiromi Watanabe; Kazuya Nishii; Chihiro Ando; Takamasa Nakasuka; Kiichiro Ninomiya; Yuka Kato; Toshio Kubo; Kammei Rai; Kadoaki Ohashi; Katsuyuki Hotta; Masahiro Tabata; Yoshinobu Maeda; Katsuyuki Kiura
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Open the PDF for in another window
DNAPK Inhibition Preferentially Compromises the Repair of Radiation-induced DNA Double-strand Breaks in Chronically Hypoxic Tumor Cells in Xenograft Models
Yanyan Jiang; Elaine Willmore; Stephen R. Wedge; Anderson J. Ryan
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
The Radiosensitizing Effect of AZD0530 in Glioblastoma and Glioblastoma Stem-Like Cells
Hong Shik Yun; Jennifer Lee; Whoon Jong Kil; Tamalee R. Kramp; Philip J. Tofilon; Kevin Camphausen
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Open the PDF for in another window
PARP and CDK4/6 Inhibitor Combination Therapy Induces Apoptosis and Suppresses Neuroendocrine Differentiation in Prostate Cancer
Cheng Wu; Shan Peng; Patrick G. Pilié; Chuandong Geng; Sanghee Park; Ganiraju C. Manyam; Yungang Lu; Guang Yang; Zhe Tang; Shakuntala Kondraganti; Daoqi Wang; Courtney W. Hudgens; Debora A. Ledesma; Mario L. Marques-Piubelli; Carlos A. Torres-Cabala; Jonathan L. Curry; Patricia Troncoso; Paul G. Corn; Bradley M. Broom; Timothy C. Thompson
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
A Novel Nrf2 Pathway Inhibitor Sensitizes Keap1-Mutant Lung Cancer Cells to Chemotherapy
Di Zhang; Zhilin Hou; Kelly E. Aldrich; Lizbeth Lockwood; Aaron L. Odom; Karen T. Liby
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Open the PDF for in another window

Large Molecule Therapeutics

Effective Killing of Acute Myeloid Leukemia by TIM-3 Targeted Chimeric Antigen Receptor T Cells
Wen-Hsin Sandy Lee; Zhiyong Ye; Alice M.S. Cheung; Y.P. Sharon Goh; Hsueh Ling Janice Oh; Ravisankar Rajarethinam; Siok Ping Yeo; Mun Kuen Soh; Esther Hian Li Chan; Lip Kun Tan; Soo-Yong Tan; Charles Chuah; Wee Joo Chng; John E. Connolly; Cheng-I Wang
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Open the PDF for in another window
Anti-Glypican-1 Antibody–drug Conjugate as Potential Therapy Against Tumor Cells and Tumor Vasculature for Glypican-1–Positive Cholangiocarcinoma
Keiichiro Yokota; Satoshi Serada; Shigehiro Tsujii; Keisuke Toya; Tsuyoshi Takahashi; Takashi Matsunaga; Minoru Fujimoto; Sunao Uemura; Tsutomu Namikawa; Ichiro Murakami; Shogo Kobayashi; Hidetoshi Eguchi; Yuichiro Doki; Kazuhiro Hanazaki; Tetsuji Naka
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Open the PDF for in another window
Recombinant Newcastle Disease Virus Immunotherapy Drives Oncolytic Effects and Durable Systemic Antitumor Immunity
James Harper; Shannon Burke; Jon Travers; Nicola Rath; Andrew Leinster; Christel Navarro; Ruth Franks; Rebecca Leyland; Kathy Mulgrew; Kelly McGlinchey; Lee Brown; Simon J. Dovedi; Jens-Oliver Koopmann; Nicholas M. Durham; Xing Cheng; Hong Jin; Jim Eyles; Robert W. Wilkinson; Danielle Carroll
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Companion Diagnostic, Pharmacogenomic, and Cancer Biomarkers

Real-world Experience of Olaparib Treatment in Patients with Ovarian Cancer: A Chinese Multicenter Study
Hong Zheng; Yunong Gao; Hongyan Guo; Li Li; Qingshui Li; Heng Cui; An Lin; Lixin Sun; Yuanjing Hu; Shan Kang; Wei Duan; Lingya Pan; Shuzhen Wang; Yingjie Yang; Yunxia Li; Weimin Kong; Yang Xiang; Xiaofei Tian; Bin Ling; Chunfang Ha; Wenpei Bai
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Models and Technologies

Development of a High-throughput NanoBRET Screening Platform to Identify Modulators of the RAS/RAF Interaction
David E. Durrant; Emily A. Smith; Ekaterina I. Goncharova; Nirmala Sharma; Patrick A. Alexander; Andrew G. Stephen; Curtis J. Henrich; Deborah K. Morrison
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Advertisement

Latest News
AI Model Could Make Cachexia Detection Easier
Drugging WRN: Clinical Proof-of-Concept Established
Using Liquid Biopsy to Guide Adjuvant ICI for dMMR Tumors
View more recent articles
Breaking
GSK Halts Trials for Anti-TIGIT Drug
GLP-1 Drugs, Surgery Equally Effective against Some Cancers
Treatment for Rare Ovarian Tumors Gets Greenlight
View more recent articles
Research Watch
ROS Sensing Regulates Mitochondrial Translation and Chemotherapy Response
Dietary Fat Promotes Triple-Negative Breast Cancer through FABP5–mTOR
Ligand Engagement Induces LAG3 Checkpoint Activity through Ubiquitination
View more recent articles

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck.  None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.

  • Online ISSN 1538-8514
  • Print ISSN 1535-7163

AACR Journals

 

 

  • Copyright © 2025 by the American Association for Cancer Research.
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept